RenovoRx Insider Surge: CEO, CFO, and Marton Laurence Stack Shares and Warrants in $10K Private Placement Ahead of Pancreatic Cancer Milestone
Insider buying fuels RenovoRx’s private placement, offering share and warrant upside as the company nears key revenue milestones.
3 minutes to read
